The Anti-NASH Effect of Namodenoson will be Presented at the International Conference on Fatty Liver in Berlin
The podium presentation will be in a session of ‘Selected Abstracts of Excellence’ Top line data from Can-Fite Phase II…
Pharmaceuticals, Biotechnology and Life Sciences
The podium presentation will be in a session of ‘Selected Abstracts of Excellence’ Top line data from Can-Fite Phase II…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement…
Long-term data demonstrate that the DynamX Bioadaptor implant and vessel growth accommodates neo-intimal hyperplasia to substantially maintain vessel lumen area…
DUBLIN–(BUSINESS WIRE)–The “India Bioreactors Market to 2027 – Country Analysis and Forecasts by Product Class; Application; Process and Geography” report…
DUNDEE, Scotland–(BUSINESS WIRE)–Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system-focused drug discovery, announced today that it had…
The completion of series B fundraise of £10.3 million The appointment of Paul Atherton as Chairman LIVERPOOL & LONDON, England–(BUSINESS…
Fund Raise Exceeds Target of €100m Total Capital Under Management Reaches €294 million DUBLIN & NEW YORK–(BUSINESS WIRE)–Fountain Healthcare Partners…
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new class of therapeutics based on…
HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and…
Enhanced senior management team to direct strategic, operational, financial, technological and business development initiatives LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTCQB: FRLI)…